Requisite Capital Management, LLC Abb Vie Inc. Transaction History

Requisite Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $183,943 - $211,838	1,272 New	1,272 $202,000
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $717,688 - $912,416	-5,215 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $329,950 - $409,375	2,500 Added 92.08%	5,215 $845,000
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $291,672 - $369,049	2,715 New	2,715 $368,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Requisite Capital Management, LLC with notifications on news.